Outcomes following KRASG12C inhibitor treatment in patients with KRASG12C-mutated solid tumors: A systematic review and meta-analysis

• Asıl Yazarlar: Qi-An Chen (Yazar), Wei-Hao Lin (Yazar), Xiao-Xiang Zhou (Yazar), Zheng Cao (Yazar), Xiao-Li Feng (Yazar), Yi-Bo Gao (Yazar), Jie He (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Elsevier, 2024-02-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Objective: To assess the efficacy and safety of FDA-approved KRASG12C inhibitors in patients with KRASG12C-mutated solid tumors. Methods: We searched PubMed, EMBASE, Cochrane Library, and major international conferences for clinical trials published in English up to March 6, 2023. Clinical trials in...